TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | -1 | 4 | 7 | 15 | 11 | 6 |
| S | %wins | 50 | 50 | 0 | 0 | 0 | 50 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/16 18:07 | 3/2/16 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bradway Robert A | CA | DO | CB,CEO,P | S.d | -2,930 | 146.48 | 33 | -20 | -5 | 403 | D | 21 | -6 | 0 | -9 | -4 | 3 | -1 | 3 | 1 | -3 | 6 | 10 | 18 | 27 |
2/12/15 21:09 | 2/11/15 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bradway Robert A | CA | DO | CB,CEO,P | S.d | -3,359 | 152.69 | 33 | -22 | -9 | 218 | D | 87 | 29 | 22 | -6 | -4 | -4 | 1 | 2 | 0 | 2 | 1 | 4 | 12 | -6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |